Want real case studies? 10 seconds to sign up
Join the platform
June 26, 2026
Approximately 5 minutes
Singapore HSA Medical Device Registration vs Dealer Licence: SHARE Decision Guide
Quick answer
Singapore regulates medical devices under the Health Products Act and Health Products (Medical Devices) Regulations 2010. Companies must hold a dealer's licence before manufacturing, importing, or supplying medical devices. Most devices also require HSA product registration before supply — except Class A low-risk devices, which require product notification in SHARE instead of full registration. All submissions are made through SHARE (Singapore Health Product Access and Regulatory E-System) for medical devices.
Who this applies to
- Manufacturers placing devices on the Singapore market
- Importers bringing devices into Singapore
- Wholesalers supplying devices locally
- Registrants responsible for product registration or notification
Device scope: Class A, B, C, and D medical devices under HSA classification.
Dealer licence vs product registration: what is the difference?
| Obligation | What it authorises | Who typically needs it |
|---|---|---|
| Dealer's licence | Legal permission tomanufacture, import, or supplymedical devices as a business activity | Manufacturers, importers, wholesalers |
| Product registration | Approval for aspecific Class B/C/D deviceto be supplied in Singapore | Registrant of the device |
| Product notification (Class A) | Notification forClass A devicesmanufactured or imported — registration exempt | Registrant of Class A devices |
You often need both a dealer licence and product registration/notification — they are not interchangeable.
SHARE portal: what you submit where
SHARE (Medical Device) supports:
- New Product Registration Application (Class B, C, D)
- Product Notification — new and amendments (Class A)
- Dealer licence applications and amendments
- Change of registrant
- Free Sale Certificate requests
- Singapore Medical Device Register (SMDR) and Class A Medical Device Database lookups
SHARE replaced MEDICS for new submissions from 14 July 2025 (ongoing MEDICS applications may transition per HSA announcements). Access requires Corppass.
Official resource: https://www.hsa.gov.sg/e-services/share-medical-device/
Class A — product notification (not registration)
HSA states Class A medical devices are exempt from product registration. However, if you manufacture or import Class A devices, you must submit a product notification application in SHARE.
Key implications:
- Class A still appears in the Class A Medical Device Database
- Do not skip notification because the device is "low risk"
- Dealer licence still required for import/manufacture/supply activities
Class B, C, D — product registration and evaluation routes
Class B, C, and D devices require product registration via SHARE using the appropriate evaluation route:
| Route | Typical use |
|---|---|
| Full evaluation | No prior approval from HSA reference agencies |
| Abridged | Prior approval from listed reference agencies on same labelled use |
| Expedited (ECR/EDR) | Class C/D with reference agency approval |
| Immediate (IBR/ICR/IDR) | Standalone medical mobile applications with reference approvals |
HSA publishes route eligibility, excluded device types, and reference agencies on its registration overview. Devices approved as Class I or Class II exempt in reference agencies do not qualify for abridged/expedited/immediate routes based on those approvals alone.
Registration dossiers follow the ASEAN Common Submission Dossier Template (CSDT) format.
Step-by-step market access workflow
- Classify the device under HSA rules (A/B/C/D).
- Determine company role — manufacturer, importer, or wholesaler.
- Apply for dealer licence in SHARE if you will manufacture/import/supply.
- For Class A: submit product notification in SHARE.
- For Class B/C/D: select evaluation route → prepare CSDT dossier → submit new product registration in SHARE.
- Upon approval, maintain change notifications, retention, and cancellation obligations as applicable.
- Verify public listing in SMDR (Class B/C/D) or Class A database.
Decision tree
Will you manufacture, import, or supply medical devices in Singapore?
├─ No → Dealer licence not required for your role
└─ Yes → Apply for dealer licence in SHARE
└─ What class is the device?
├─ Class A → Product notification in SHARE (registration exempt)
└─ Class B/C/D → Product registration in SHARE (select evaluation route)
Checklist
- HSA device class confirmed (A/B/C/D)
- Company role identified (manufacturer/importer/wholesaler)
- Dealer licence applied or held
- Class A notification submitted (if applicable)
- Class B/C/D evaluation route selected
- CSDT dossier prepared
- SHARE Corppass access configured
- Reference agency approvals verified for expedited routes
- SMDR / Class A database listing verified post-approval
Common pitfalls
- Assuming Class A needs no HSA filing — notification is still required.
- Confusing dealer licence with product registration — both may be required.
- Using MEDICS after SHARE cutover — new applications go to SHARE.
- Choosing expedited route without eligible reference approval — leads to rejection or re-routing.
- Reference approval on different intended use — must match Singapore labelled use.
- Ignoring change notification obligations after initial approval.
FAQ
Do Class A devices need HSA registration?
No full registration — but product notification in SHARE is required when you manufacture or import Class A devices.
What is SHARE for medical devices?
SHARE is HSA's portal for product registration, Class A notification, dealer licences, change of registrant, and related services.
Can I import Class B devices without a dealer licence?
No — companies need a dealer's licence before importing or supplying medical devices.
What dossier format does HSA use?
ASEAN CSDT for Class B, C, and D registration submissions.
What evaluation routes exist for Class C and D?
Full, abridged, and expedited (ECR/EDR) routes depending on reference agency approvals and device type.
When did SHARE replace MEDICS?
HSA announced SHARE launch for new medical device submissions from 14 July 2025.
Official sources
- HSA — Regulatory overview: https://www.hsa.gov.sg/medical-devices/regulatory-overview
- HSA — Registration overview: https://www.hsa.gov.sg/medical-devices/registration/overview
- HSA — SHARE (Medical Device): https://www.hsa.gov.sg/e-services/share-medical-device/
- HSA — Dealer licence: https://www.hsa.gov.sg/medical-devices/manufacturing-import-and-supply/dealers-licence/
- HSA — SHARE announcement: https://www.hsa.gov.sg/announcements/introducing--share----your-digital-portal-for-medical-devices/
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
Registered Pharmacist · AI Engineer · Director, ElendiLabs
Registered pharmacist, AI engineer, HKHAIS founder, and pharmaceutical & medical device SEO/GEO specialist.
Ask Anything
We'll follow up with you personally.
100% response rate • Reply within 7 business days
Related Articles
Approximately 5 minutes
How to Register Therapeutic Products in Singapore: HSA Eligibility, Application Types, Evaluation Routes and Pre-Submission Requirements
HSA Singapore mandates that only ACRA-registered local companies may apply for therapeutic product registration (chemical or biological entities) via PRISM. Applicants must select NDA or GDA application types, choose among Full, Abridged, Verification or Verification-CECA evaluation routes, prepare ICH CTD or ACTD dossiers, complete patent declarations and ensure GMP compliance for overseas manufacturers.
Approximately 5 minutes
Singapore HSA Drug Master File Submission for Therapeutic Products
HSA requires Drug Master Files (DMFs) to be submitted only in conjunction with a therapeutic product application; they contain confidential manufacturing details divided into open and closed parts, with notification via an online form required before submission of PDF dossiers.
Approximately 5 minutes
Navigating the Kazakhstan Medical Device Market: National Pathway vs. EAEU Regulatory Compliance
An expert compliance blueprint for Kazakhstan and the Central Asia MedTech market for 2026. Meditor analyzes the indefinite validity of the National pathway before the 2027 deadline, Class 2A/2B registration costs, physical site audits, and CE mark advantages.